SOLUTION

SMART MANUFACTURING

of mRNA-based vaccines and therapeutics

Dillico is developing an infrastructure of digital tools, equipment and services tailored to your mRNA-LNP production needs, to help you meet the challenges you face. Our proprietary flow-technology solution allows the same piece of equipment to produce mRNA vaccine and therapeutics at any scale, from early development to commercial manufacturing, while offering unique real-time and remote monitoring capabilities, thus facilitating operations and technology transfers.

All-ScaleFlow™– BASED EQUIPMENT

removes major industrial roadblocks in the production of mRNA-LNP making it both unique and competitive

PROCESS INTENSIFICATION

At the core of our solution

Quality

Fully enclosed, monitored and digitalized process

Direct Scale-up & Flexibility

1.000 doses in a few hours to 30 million+ doses per year

Optimized cost

Fully enclosed, monitored and digitalized process

Manufacturing at a regional level

4 sq/m footprint automated equipment with remote control capabilities

Sustainability

to build a better future

Flexibility

Full production volume flexibility

Waste Reduction

Less Single Use plastic items

Broad Accessibility

Less reliance on cold chain, supply chain and shortage of skilled operators

GHG Emission Reduction

Simplified logistic transport and cold chain

Headquarters